Mapi – Pharma Ltd Files SEC Form FWP, Filing Under Securities Act Rules 163/433 of Free Writing Prospectuses (Jun. 30, 2014)

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Mapi – Pharma Ltd (Form FWP) was posted on June 30, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There were 29 documents filed with this form. The SEC file number is 0001178913-14-002187.
The contact information for this company is 16 EINSTEIN ST., P.O BOX 4113, WEIZMANN SCIENCE PARK, NESS ZIONA L3 74140, 972-73-7121213.
Our editors provided additional information about Form FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1595380/0001178913-14-002187-index.html.
Keywords for this news article include: Pharmaceutical Preparations, SEC Filing, Mapi – Pharma Ltd.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC